Literature DB >> 18820813

[Metabolic Syndrome in professional truck drivers who work on Highway BR-116 within the area of São Paulo City - Régis Bittencourt].

Luciane Cesira Cavagioni1, Isabela M Bensenõr, Alfredo Halpern, Angela M G Pierin.   

Abstract

The objective of this study was to determine the Metabolic Syndrome prevalence as well as identify variables related in truck drivers who work on Highway BR-116 (São Paulo, Brazil). A total of 258 truck drivers were assessed and the variables studied were: body mass index, waist circumference, blood pressure, triglycerides, total and fraction cholesterol, glycemia and C reactive protein. Cardiovascular disease risk was evaluated by Framingham's risk score whereas the Metabolic Syndrome based on the First Brazilian Guideline for Diagnosis and Treatment of the Metabolic Syndrome. The significance level adopted was p< 0.05 and univariate and multivariate analysis were applied. The average age was of 37.5+/-10.1. According to the anthropometric data, it was observed body mass index > or =25 kg/m(2) in 82%, waist circumference > or =94 cm in 58%, total cholesterol >240 mg/dL in 9%, LDL-c >160 mg/dL in 10%; HDL-c <40 mg/dL in 20%, triglycerides >200mg/dL in 22%, glycemia >110 mg/dL in 7%, and C reactive protein >0.5 mg/dL in 19%. Hypertension prevalence was 37%, 9% were identified at the highest/medium Framingham's risk score and 24% showed Metabolic Syndrome. The logistical regression analysis indicated independent association of the Metabolic Syndrome for the following variables (OD odds ratio, CI confidence interval at 95%): body mass index (OR = 1.4007 CI 95% 1.192-1.661), use to check cholesterol (OR = 0.1020 CI 0.017-0.589) and Framingham's risk score (OR = 26.389 CI 2.520-276.374). As a conclusion, it was observed a quite expressive prevalence of cardiovascular risk factors as well as Metabolic Syndrome in truck drivers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820813     DOI: 10.1590/s0004-27302008000600013

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  6 in total

Review 1.  Metabolic syndrome and its determinants among professional drivers: a systematic review and meta-analysis.

Authors:  Nazanin Izadi; Arezu Najafi; Maryam Saraei
Journal:  J Diabetes Metab Disord       Date:  2021-11-03

2.  General characteristics and risk factors of cardiovascular disease among interstate bus drivers.

Authors:  Raquel Pastréllo Hirata; Luciana Maria Malosa Sampaio; Fernando Sergio Studart Leitão Filho; Alberto Braghiroli; Bruno Balbi; Salvatore Romano; Giuseppe Insalaco; Luis Vicente Franco de Oliveira
Journal:  ScientificWorldJournal       Date:  2012-06-04

3.  Association of metabolic syndrome and albuminuria with cardiovascular risk in occupational drivers.

Authors:  Szu-Chia Chen; Jer-Ming Chang; Ming-Yen Lin; Meng-Ling Hou; Jer-Chia Tsai; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Int J Mol Sci       Date:  2013-11-06       Impact factor: 5.923

4.  Relation between uric acid and metabolic syndrome in subjects with cardiometabolic risk.

Authors:  Hellen Abreu da Silva; Júlia Cristina Cardoso Carraro; Josefina Bressan; Helen Hermana Miranda Hermsdorff
Journal:  Einstein (Sao Paulo)       Date:  2015-05-19

5.  Prevalence of metabolic syndrome and related factors in bank employees according to different defining criteria, Vitória/ES, Brazil.

Authors:  Luciane Bresciani Salaroli; Renata Aubin Dias Saliba; Eliana Zandonade; Maria del Carmen Bisi Molina; Nazaré Souza Bissoli
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

6.  Prevalence of cardiovascular risk factors among truck drivers in the South of Brazil.

Authors:  Carine Teles Sangaleti; Maria Regiane Trincaus; Tatiane Baratieri; Kaline Zarowy; Maria Bernardete Ladika; Mario Umberto Menon; Ricardo Yoshimitsu Miyahara; Maria Isabel Raimondo; João Vicente Silveira; Luis Aparecido Bortolotto; Heno Ferreira Lopes; Fernanda M Consolim-Colombo
Journal:  BMC Public Health       Date:  2014-10-11       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.